Seeking Alpha

Impax Laboratories downgraded

  • Impax Laboratories (IPXL -0.1%) catches a downgrade to Underperform from Neutral at Buckingham Research.
  • Price target is $15 (unchanged from previous), nearly 31% below Friday's close.
Comments (1)
  • Nobs
    , contributor
    Comment (1) | Send Message
    Not surprisng, considering the turmoil inside the company.
    12 Aug 2013, 03:28 PM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio: